India plans to expand its vast but faltering coronavirus vaccination programme from March 1 by offering jabs to the over 60s, the government said Wednesday.
The country began vaccinating its 1.3-billion population last month and plans to inoculate 300 million people by July, but so far the rollout has been limited to healthcare workers and other frontline staff.
However, from Monday people over 60 and those over 45 with multiple medical conditions can be vaccinated for free at 10,000 government hospitals and nearly 20,000 private clinics for a charge.
“Those who want to get vaccinations from private hospitals will have to pay. The amount to be paid will be decided and declared by the health ministry within the next three to four days,” Union Minister Prakash Javadekar said after a cabinet meeting.
The vaccination programme, one of the world’s largest, has so far seen 12.2 million shots administered, according to the health ministry.
But at the current pace it will take several years to inoculate 300 million people.
The vaccines being used are the AstraZeneca jab, made domestically by Indian giant the Serum Institute, and the homegrown Covaxin developed by Bharat Biotech, which is yet to complete trials.
The makers of Russia’s Sputnik V have also applied for emergency use approval.
The head of Serum, which other poor countries are relying on for supplies of the AstraZeneca vaccine, said on Sunday it had been “directed to prioritise the huge needs of India”.
Some regions of the country have seen an uptick in infections in recent weeks including in the western state of Maharashtra, which has imposed new restrictions on gatherings.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
India to vaccinate over-60s from March 1 (2021, February 24)
retrieved 24 February 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022